Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

INTRODUCTION: Dendritic cells (DCs) are antigen-presenting cells that are currently employed in cancer clinical trials. However, it is not clear whether their ability to induce tumour-specific immune responses when they are isolated from cancer patients is reduced relative to their ability in vivo....

Descripción completa

Detalles Bibliográficos
Autores principales: Gervais, Alban, Levêque, Jean, Bouet-Toussaint, Françoise, Burtin, Florence, Lesimple, Thierry, Sulpice, Laurent, Patard, Jean-Jacques, Genetet, Noelle, Catros-Quemener, Véronique
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143555/
https://www.ncbi.nlm.nih.gov/pubmed/15987427
http://dx.doi.org/10.1186/bcr1001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143555/
https://www.ncbi.nlm.nih.gov/pubmed/15987427
http://dx.doi.org/10.1186/bcr1001

Ejemplares similares